HIGHLIGHTS
- who: Christina Deligianni from the University of Erlangen Nuremberg, Germany have published the article: Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study, in the Journal: (JOURNAL)
- what: During the study, the randomization code remained in the hospital and was unavailable to blinded medical investigators until the study was completed and data were analyzed. adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in the pathogenesis of cluster headache . The study is part of a previously conducted parent study approved by the Ethical Committee of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.